Literature DB >> 14484448

Quantitative studies on viral interference in suspended L cells. I. Growth characteristics and interfering activities of vesicular stomatitis, Newcastle disease, and influenza A viruses.

K PAUCKER, Z SKURSKA, W HENLE.   

Abstract

Entities:  

Keywords:  INFLUENZA VIRUSES/culture; NEW CASTLE DISEASE/virology; STOMATITIS/virology; ULTRAVIOLET RAYS; VIRUSES/culture

Mesh:

Year:  1962        PMID: 14484448     DOI: 10.1016/0042-6822(62)90121-6

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


× No keyword cloud information.
  7 in total

1.  Viral auto-inhibition studied by the effect of anti-interferon serum on plaque formation.

Authors:  B Fauconnier
Journal:  Arch Gesamte Virusforsch       Date:  1970

2.  Purification, characterization, and attempts at isotopic labeling of mouse interferon.

Authors:  K Paucker; B J Berman; R R Golgher; D Stancek
Journal:  J Virol       Date:  1970-02       Impact factor: 5.103

Review 3.  Cellular resistance to induction of interferon.

Authors:  K Paucker; M Boxaca
Journal:  Bacteriol Rev       Date:  1967-06

4.  Relation of interferon synthesis to abortive replication of Newcastle disease virus in L cells.

Authors:  J S Youngner; A W Scott
Journal:  J Virol       Date:  1968-01       Impact factor: 5.103

5.  Oligonucleotide fingerprints of RNA species obtained from rhabdoviruses belonging to the vesicular stomatitis virus subgroup.

Authors:  J P Clewley; D H Bishop; C Y Kang; J Coffin; W M Schnitzlein; M E Reichmann; R E Shope
Journal:  J Virol       Date:  1977-07       Impact factor: 5.103

6.  PRODUCTION OF AN INTERFERON BY L CELLS INFECTED WITH WESTERN EQUINE ENCEPHALOMYELITIS VIRUS.

Authors:  R Z LOCKART
Journal:  J Bacteriol       Date:  1963-03       Impact factor: 3.490

7.  Interferon production by inactivated Newcastle disease virus in cell cultures and in mice.

Authors:  J S Youngner; A W Scott; J V Hallum; W R Stinebring
Journal:  J Bacteriol       Date:  1966-10       Impact factor: 3.490

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.